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Recommendations for Management of Equine Athletes with
Cardiovascular Abnormalities
V.B. Reef, J. Bonagura, R. Buhl, M.K.J. McGurrin, C.C. Schwarzwald, G. van Loon, and L.E. Young
Murmurs and arrhythmias are commonly detected in equine athletes. Assessing the relevance of these cardiovascular
abnormalities in the performance horse can be challenging. Determining the impact of a cardiovascular disorder on perfor-
mance, life expectancy, horse and rider or driver safety relative to the owner’s future expectations is paramount. A com-
prehensive assessment of the cardiovascular abnormality detected is essential to determine its severity and achieve these
aims. This consensus statement presents a general approach to the assessment of cardiovascular abnormalities, followed by
a discussion of the common murmurs and arrhythmias. The description, diagnosis, evaluation, and prognosis are consid-
ered for each cardiovascular abnormality. The recommendations presented herein are based on available literature and a
consensus of the panelists. While the majority of horses with cardiovascular abnormalities have a useful performance life,
periodic reexaminations are indicated for those with clinically relevant cardiovascular disease. Horses with pulmonary
hypertension, CHF, or complex ventricular arrhythmias should not be ridden or driven.
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Cardiac murmurs and arrhythmias are often identi-ﬁed in horses engaged in all levels of performance
across the entire spectrum of equine sports. The chal-
lenge for the clinician is to determine the impact of
any cardiovascular (CV) abnormality on present and
future performance, on rider or driver and horse
safety, and to consider any long-term eﬀects on health
and longevity.
The recommendations contained herein were devel-
oped during recurrent and protracted discussions with
active participation by all 7 panelists. The available lit-
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Abbreviations:
AF atrial ﬁbrillation
AIVR accelerated idioventricular rhythm
AR aortic regurgitation
AVB atrioventricular block
AVP aortic valve prolapse
CHF congestive heart failure
cTnI cardiac troponin I
CV cardiovascular
ECG electrocardiogram
HR heart rate
IRAF immediate recurrence of AF
LA left atrium or left atrial
LVD left ventricular dysfunction
LV left ventricle or left ventricular
MR mitral regurgitation
MVP mitral valve prolapse
NSR normal sinus rhythm
PAC premature atrial complex
PHT pulmonary hypertension
PVC premature ventricular complex
RA right atrium or right atrial
RCT ruptured chordae tendineae
RV right ventricle or right ventricular
SCD sudden cardiac death
SNS sympathetic nervous system
TR tricuspid regurgitation
TVEC transvenous electrical cardioversion
VA ventricular arrhythmias
VSD ventricular septal defect
VT ventricular tachycardia
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erature (including high-grade research evidence, retro-
spective studies, and case reports) was used whenever
possible. However, since pertinent literature in many
important areas is quite limited, our collective personal
experience constitutes the basis of most of these guide-
lines. As might be expected, some clinical issues were
associated with more divergent opinions than others;
but overall, the panelists achieved “consensus” (indi-
cating that 6 to 7/7 panelists supported the recommen-
dation). We emphasize that the following guidelines
pertain speciﬁcally to horses used in performance-
based activities and are not necessarily generalizable to
all horses. Furthermore, the reader should anticipate
that modiﬁcations in these recommendations will occur
based on the results of future research, including that
recommended by the panel at the conclusion of this
report.
General Approach
These recommendations for equine athletes presume
familiarity and clinical expertise in equine auscultation,
echocardiography, electrocardiography (ECG), exercise
testing, and interpretation of laboratory testing, along
with a thorough understanding of the pathophysiology
of equine heart disease.1–4 Most management decisions
and risk assessments are based on these evaluations
along with the performance history, physical examina-
tion ﬁndings, athletic demands placed on the horse
and owner expectations.
Most cardiac lesions can be “graded” as mild, mod-
erate, or severe. Prognosis tends to track these grades,
accepting that forecasting the performance longevity
and lifespan of an equine athlete with a “mild” or
“severe” heart disease is relatively straightforward
when compared to a lesion of “moderate” severity that
might be well-tolerated or rapidly decompensating.
Horses with a deﬁned cardiac lesion warrant a sche-
dule of follow-up examinations to reﬁne the prognosis,
reassure the horse owner, and anticipate and manage
medical complications. Objective, negative prognostic
factors in the setting of structural heart disease include
progressive chamber remodeling (dilatation and altered
chamber shape) and dysfunction, great vessel enlarge-
ment, as well as the development of pulmonary hyper-
tension (PHT), congestive heart failure (CHF), and
potentially dangerous arrhythmias. Horses with PHT,
CHF, or complex ventricular arrhythmias (VA) are
unsafe to ride or drive and should be managed with
standard therapy for these problems.
Echocardiography
The history, cardiac rhythm, and the results of aus-
cultation should be known before interpreting the
echocardiogram. The Panel speciﬁcally recommends an
echocardiogram in the following situations: (1) a previ-
ously diagnosed “functional” murmur that is louder
on serial examinations; (2) a grade 3–6/6 left-sided
murmur compatible with mitral regurgitation (MR) or
aortic regurgitation (AR); (3) a grade 4–6/6 right-sided
systolic murmur compatible with tricuspid regurgita-
tion (TR); (4) suspected ventricular septal defect
(VSD) or other congenital heart lesion; (5) continuous
or combined systolic-diastolic murmurs; (6) clinically
important arrhythmias, whether a murmur is present
or not; (7) suspected myocardial injury; or (8) suspi-
cion of CHF. However, there are other clinical situa-
tions when echocardiography also provides valuable
information.
A complete echocardiographic study should address
the following: (1) morphologic lesions; (2) motion
abnormalities; (3) cardiac chamber and great vessel
size; (4) cardiac valve function; (5) blood ﬂow distur-
bances; (6) global and regional ventricular systolic
function; (7) estimates of hemodynamic variables
including pressure gradients and volumetric ﬂow; and
(8) ventricular diastolic function and ﬁlling pressures
(accepting these two are challenging to measure in
mature horses). A comprehensive assessment requires
the application of complementary 2D, M-mode, and
Doppler modalities.
Exercise Testing
Exercise testing is an important component of CV
assessment and includes continuous recording of the
ECG. Exercising ECGs should only be obtained with
a device that has permanent storage and playback
capabilities.4–6 Work intensity should be at or slightly
exceeding the horse’s customary activities. Some
method of inducing unexpected sympathetic stimula-
tion should be included in the exercise test to identify
an inappropriate HR, aberrant conduction, or ectopy
associated with adrenergic stimulation. In horses with
clinically important structural lesions, intermittent pre-
mature complexes, or lone AF that cannot be con-
verted to sinus rhythm, exercise testing can determine
if the HR is appropriate for the work performed or if
an arrhythmia deteriorates over the course of the test.
Exercise testing is also indicated during a prepurchase
examination when a nonfunctional heart murmur or
sporadic arrhythmia is identiﬁed. An exercise test
should not be performed when there is CHF, severe
valvular regurgitation with secondary AF, PHT, or
severely reduced systolic function or when a ventricu-
lar arrhythmia of dangerous complexity is present.
Speciﬁc noninvasive cardiac assessments include (1)
the eﬀects of exercise on auscultation (rate, rhythm,
and murmurs); (2) peak HR during exercise; (3) HR
and rhythm during the diﬀerent phases of the exercise
test and during recovery; and, optionally, (4) echocard-
iography before and after exercise (stress echocardio-
gram). Additional tests that might be indicated are
analysis of gait, airway dynamics, arterial blood gas
tensions, and other clinical laboratory tests.
Cardiac Murmurs
Both functional and clinically relevant cardiac mur-
murs are common in horses (Table 1). Mild valvular
regurgitation is often detected in horses with soft
750 Reef et al
murmurs, and seemingly does not aﬀect performance
or health.7 Loudness of the murmur need not correlate
with severity, especially with musical murmurs or in
the setting of CHF.
A complete echocardiogram is the diagnostic test of
choice when evaluating a horse with a cardiac mur-
mur2,3 and is advised (1) when auscultatory or clinical
ﬁndings are not consistent with a physiologic murmur;
(2) if the murmur is moderate to loud; or (3) on
occasion, when a murmur is detected as part of a pre-
purchase examination. Serial echocardiographic evalua-
tions are more meaningful for prognostication than
ﬁndings from a single examination. A number of
Doppler ﬁndings, including the width of the vena con-
tracta and the regurgitant jet area, are used to assess val-
vular regurgitation,8 but these variables are unreliable in
isolation. For example, in the absence of cardiac cham-
ber enlargement, it is unlikely that chronic, severe regur-
gitation is present, regardless of the Doppler ﬁndings.
Furthermore, Doppler studies often reveal physiological
valvular regurgitation that is silent on auscultation.
Mitral Regurgitation
MR is a common ﬁnding in horses performing in all
sports disciplines. Murmurs of MR can be mid-to-late
Table 1. Cardiac murmurs.
Left/Right Side Thorax Diagnosis Typical Auscultatory Findings Comments
Left side thorax
Systolic murmur Physiologic (ﬂow)
murmur
PMI over aortic and pulmonic
valve area
Early-to-midsystolic
Crescendo-decrescendo or
decrescendo
Usually grade 1–3/6
Assumed to be caused by blood
ﬂow in aorta and pulmonary
artery in early systole
Generally localized and brief
in duration
Intensity might change with
exercise
Mitral regurgitation PMI over mitral to aortic valve
Holo- or pansystolic or
mid-to-late systolic
Plateau (band-) shaped or
mid-to-late crescendo
Grade 1–6/6
Crescendo mid-to-late systolic
murmur suggestive of mitral
valve prolapse
Musical holosystolic or mid-to-
late systolic honking murmur
suggestive of ruptured chordae
tendineae
Ventricular septal defect
(subarterial)
PMI pulmonic valve area
Plateau (band)-shaped
Grade 4–6/6
Often heard on right side but
less loud
Less common location
Must distinguish from right
ventricular outﬂow obstruction
Diastolic murmur Physiologic (ﬂow)
murmur
PMI over mitral & tricuspid
valve area
Early-diastolic (S2-S3) or
late-diastolic (S4-S1)
Quality often musical/squeaking
Grade 1–3/6
Assumed to be caused by
ventricular ﬁlling
Aortic regurgitation PMI over aortic valve area
Holo- or pandiastolic
Decrescendo, musical, or both
Grade 1–6/6
Usually radiates to the right as a
slightly softer, but otherwise
similar murmur
Systolic with diastolic
component
Aorto-pulmonary
ﬁstula
(predominantly
reported in Friesians)
PMI dorsal to aortic valve area
Holosystolic and
early-to-middiastolic
Can be fairly localized
Bounding arterial pulses
Usually tachycardic
Right side thorax
Systolic murmur Tricuspid regurgitation PMI over tricuspid valve
Holo- or pansystolic
Crescendo or band shaped
Grade 1–6/6
Usually soft and blowing
Ventricular septal defect
(perimembranous)
PMI ventral to tricuspid valve
Holo- or pansystolic
Plateau (band-) shaped
Grade 4–6/6
Usually coarse
Often a softer crescendo-
decrescendo murmur over
pulmonic valve heard because of
relative pulmonic stenosis
Continuous Aorto-cardiac ﬁstula PMI right side, also audible
on left
Harsh machinery
Grade 3–6/6
Bounding arterial pulses
Ventricular arrhythmias common
initially
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systolic or holo/pansystolic (Table 1). When MR is
mild, it is usually associated with normal performance7
and life expectancy.9–12
Some of the underlying lesions responsible for MR
can be visualized by 2D echocardiography, including
mitral valve dysplasia, degenerative or inﬂammatory
valve thickening (including bacterial endocarditis), pro-
lapse (MVP), thickened or ruptured chordae tendineae
(RCT), and ﬂail leaﬂet. MR also can develop second-
ary to valve annulus or ventricular dilatation (as with
severe AR, nonrestrictive VSD or rarely, dilated car-
diomyopathy).
Diagnosis and Evaluation. The mitral valve and sup-
port apparatus should be thoroughly examined by 2D
and M-mode echocardiography for structural and
motion abnormalities and identiﬁcation of the most
likely etiology for MR. Valvular or chordal thickening
might be evident, but in mild cases, judgments will be
subjective. The echocardiographic diagnosis of MVP
has not been well deﬁned in the horse, and the saddle-
shape of the valve makes the diagnosis challenging.
Convex bulging of a mitral leaﬂet into the left atrium
(LA) along with a mid-to-late systolic murmur and
Doppler conﬁrmation of MR are ﬁndings consistent
with MVP. A RCT is detected as an echoic, whip-like
structure moving into the LA during systole which
ﬂips into and out of the imaging plane.13 A ﬂail leaﬂet
is diagnosed when part of the valve leaﬂet is imaged in
the LA and moving chaotically or independently from
the rest of the mitral valve.13 Endocarditis often
appears as focal-raised lesions on the surface of the
valve or as oscillating vegetations or thrombi attached
to the valve.
Except in cases of acute MR associated with endo-
carditis, chordal rupture, or papillary muscle dysfunc-
tion, there should be progressive changes in LA and
left ventricular (LV) size and shape that reﬂect the
severity of MR. An absence of remodeling is consistent
with mild MR. Marked enlargement and signs of PHT
are typical of severe MR.13 In the absence of pulmo-
nary artery (PA) catheterization, TR velocity and PA
dilatation are used as surrogates for the identiﬁcation
of PHT. Assessment of LV systolic function can be
confusing because of increased preload and reduced
afterload. When MR is acute and severe, the LV will
be hyperdynamic with increased fractional shortening.
Diastolic compression of the right ventricle (RV) with
exuberant septal motion also suggests severe LV vol-
ume overload. Chronic MR associated with progres-
sive remodeling and left ventricular dysfunction (LVD)
can lead to the fractional shortening returning to the
normal range or being obviously reduced.
Importantly, a MR jet that is eccentric, wall-hug-
ging, or ﬂat can lead to underestimation of severity.
Multiple jets are often present and the short-axis image
plane and other cardiac windows can be useful to iden-
tify these. A number of color and spectral Doppler
methods are used to assess severity of MR in humans8
and are also used by some panelists in horses. How-
ever, the examiner must fully appreciate the limitations
of these Doppler techniques.
Prognosis (Table 2). Assessing the severity of MR
and predicting its clinical course are diﬃcult. Horses
with a mid-to-late crescendo murmur and mild MR
usually have a favorable prognosis. Although MR is
unlikely to aﬀect performance unless it is relatively
severe, LA enlargement increases the risk for AF.
Major negative prognostic indicators for horses with
MR include moderate to severe regurgitation, endocar-
ditis, RCT, ﬂail leaﬂet, severe valvular thickening, con-
current PA dilatation, increased TR velocity, or
signiﬁcant MR with AF or tachycardia.10,13
Summary: Key Recommendations for MR
 Determine the most likely etiology.
 Assess severity based on combined assessment of
performance history, exercise testing, clinical
examination, and echocardiographic ﬁndings.
 Reexamine at least annually or, for mild MR,
every other year.
 Ensure that HR and rhythm are monitored on a
regular basis in horses with moderate to severe
MR.
 Perform ECG exercise test in (1) all horses with
moderate to severe MR; (2) if AF becomes estab-
lished (see below); or (3) if MR progresses more
rapidly than expected, in the absence of signs of
CHF.
 Manage complications of advanced disease. Lim-
ited data have been published about ACE inhibi-
tors and no consensus could be reached
regarding their use in MR in the absence of
CHF.
Aortic Regurgitation
AR is a common ﬁnding in older horses. The mur-
mur is often detected incidentally.14 Any left-sided ho-
lodiastolic murmur is assumed to indicate AR unless
proven otherwise. Degenerative valve thickening and
aortic valve prolapse are most frequently detected.14,15
Other causes include congenital malformations, leaﬂet
tearing, infective endocarditis, valvulitis, fenestrations,
and aortic root disease. AR is also observed in associa-
tion with some VSDs (see below).
The condition is often mild and associated with nor-
mal performance and life expectancy.12 However, when
AR is moderate to severe or ﬁrst recognized in a youn-
ger horse (<10 years of age), the risks for reduced per-
formance life and longevity are higher. SCD associated
with fatal VA has been observed in horses with moder-
ate to severe AR and can occur in isolation, without a
history of poor performance or CHF.
Diagnosis and Evaluation. Bounding or hyperdynam-
ic arterial pulses suggest hemodynamically severe AR
with LV volume overload.14 Noninvasive blood pres-
sure measurement can identify widening of pulse pres-
sure.16 An exercising ECG is recommended when
moderate to severe AR or performance issues are evi-
dent. This evaluation should be focused on identifying
exercise-induced premature ventricular complexes
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(PVCs) and appropriateness of the exercising HR. A
continuous 24 hour-Holter ECG can be considered to
further identify and quantitate any VA.
2D echocardiography frequently demonstrates valve
thickening as a ﬁbrous band-like lesion, which appears
usually as an echoic line parallel to the free edge of the
left coronary leaﬂet.14 Less often, nodular thickening
or a generalized increase in echogenicity of the leaﬂet’s
free edge is detected. Leaﬂet prolapse into the LV out-
ﬂow tract, especially involving the noncoronary cusp, is
another common ﬁnding. False positive diagnoses are
common with misalignment of the ultrasound beam.15
A jet of AR surrounding the prolapsed portion of the
leaﬂet should be evident by color Doppler imaging.
Diastolic ﬂuttering or vibrations aﬀecting the free edge
of a leaﬂet, especially the left coronary cusp, are often
observed in horses with musical AR murmurs, consis-
tent with degeneration and redundancy or fenestration
of the leaﬂet. A ﬂail leaﬂet is detected rarely and indi-
cates a torn or avulsed portion of the valve. Endocar-
ditic lesions are an uncommon cause of AR and can be
evidenced as raised lesions, an oscillating thrombus, or
mild to severe thickenings depending on the severity
and chronicity of disease.
M-mode studies demonstrate diastolic ﬂuttering of the
mitral14 or aortic valves, aortic root, or interventricular
Table 2. Prognostic guidelines for performance of horses aﬀected with mitral and aortic regurgitation.a
Excellent Fair Guarded to Poor
Mitral regurgitation
Arterial pulses Normal Normal Weak
Valve lesion None, mild MVP Mild thickening, mild
dysplasia
Severe thickening, RCT, ﬂail
leaﬂet, endocarditis, severe
dysplasia
LA enlargement Absent or mild Mild to moderate Moderate to severe or
progressive
LA shape Normal Normal or slightly rounded Might appear round and turgid
Interatrial septum Normal Normal Might be bulging toward RA
LV volume overload Absent Mild Moderate to severe
LV systolic function Normal Normal Hyperdynamic, normal (less
than expected) or decreased
Pulmonary vein enlargement Absent Absent Usually present
PA enlargement Absent Absent Present or developing
MR jetb One or multiple small &
narrow jets
One or more medium-sized jets Large single or large multiple
jets
AF, PACs Absent Pre-existing Secondary
Aortic regurgitation
Arterial pulses Normal Normal or slightly bounding Bounding or weak
Arterial blood pressure Normal Pulse pressure >60 mmHg
Valve lesion None, parallel ﬁbrous band,
mild AVP
Nodular thickening, moderate
AVP suspected fenestration
Severe thickening or AVP, ﬂail
leaﬂet, endocarditis,
congenital malformation
Aortic root Normal Normal or mild enlargement Mild to severe enlargement
LV volume overload Absent or mild Mild to moderate Moderate to severe
LV systolic function Normal Hyperdynamic Hyperdynamic or decreased
AR jetb One or 2 small & narrow jets
Long pressure half-timec
One or more medium-sized jets Large single or large multiple
jets
Short pressure half-timec
LA enlargement Absent Absent or mild Mild to severe
Concurrent MR Absent Absent or pre-existing Secondary to AR
PA enlargement Absent Absent Present
Ventricular arrhythmias Absent Absent PVCs, VT
AF Absent Pre-existing Secondary
Age at onset Older Middle age Young
aCombined assessments are essential in accurately formulating a prognosis for life and performance and should include lesions
detected, size of cardiac chambers, myocardial function, color Doppler assessment of jet, Doppler (CW)/hemodynamic estimates, age at
onset, and intended use of horse.
b“Jet” includes both the width of the regurgitant ﬂow at the valve oriﬁce (at the vena contracta) and the jet area relative to the receiv-
ing chamber area, in which case the “jet” likely includes entrained RBCs. Width of the jet at the valve oriﬁce is diﬃcult to measure accu-
rately because of dynamic, nonuniform, three-dimensional structure at the vena contracta. Jet area is highly dependent on technical
factors including ultrasound beam angle, transducer distance from the region of interest, transducer frequency, 2D and color gain and
ﬁlter settings, pulse-repetition frequency, and image plane.
cPressure half-time cannot be accurately measured unless the interrogating beam is maintained at a constant angle with the regurgitant jet.
AF, atrial ﬁbrillation; AR, aortic regurgitation; AVP, aortic valve prolapse; LA, left atrial; LV, left ventricular; MR, mitral regurgita-
tion; MVP, mitral valve prolapse; PA, pulmonary artery; PAC, premature atrial complex; PVC; premature ventricular complex; RA,
right atrium; RCT, ruptured chordae tendineae; VT, ventricular tachycardia.
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septum should the jet of AR impinge one of these
structures. Eccentric jets directed toward the mitral valve
can prevent full opening of that leaﬂet. Premature clo-
sure of the mitral valves on M-mode echocardiography
is a sign of markedly increased LV end-diastolic pressure
and indicates severe AR.
Comments made previously about volume overload,
remodeling, PHT, and LV systolic function for MR are
also appropriate for AR. Enlargement of the aortic root
can occur with long-standing moderate to severe AR.14
LA dilatation suggests ventricular dysfunction, volume
retention, or concurrent MR. The latter can develop
because of AR-induced dilatation of the LV, mitral
annulus, and LA or from degenerative mitral disease.
Assessment of LV systolic function is diﬃcult, especially
in acute AR, but with chronic disease overt LVD might
be observed. CW Doppler studies including regurgitant
signal duration and intensity, pressure half-time, and
velocity time integral of AR compared to forward ﬂow
are used in humans8 and could have merit in horses.
Prognosis (Table 2). Assessing AR severity and pre-
dicting its clinical course are challenging. Findings
compatible with mild AR that are unchanged at fol-
low-up examinations relate to a better prognosis for
work and life. The detection of hyperkinetic arterial
pulses or a pulse pressure of >60 mmHg suggests that
progression of AR is likely.16 All panelists agreed that
horses with severe AR should not be ridden or driven
by a child, used as a lesson horse, or participate in a
high-risk sport owing to a risk for SCD. Although AR
is unlikely to aﬀect performance unless it is severe,
once LA enlargement occurs, the risks of AF, PHT,
and CHF are higher.
Summary: Key Recommendations for AR
 Determine the most likely etiology.
 Assess severity based on combined assessment of
performance history, exercise testing, clinical
examination, and echocardiographic ﬁndings.
 An exercise ECG is indicated in a horse with
moderate to severe AR.
 Reexamine twice yearly when there is moderate
to severe AR (including echocardiography and
ECG exercise test) and at least annually thereaf-
ter if progression has been minimal. Similarly,
longer follow-up intervals are appropriate for
horses with mild AR after the ﬁrst re-evaluation.
 If AF develops in a horse with mild to moderate
AR, a reexamination is indicated at that time,
including an ECG exercise test.
 Ensure HR and rhythm are monitored on a regu-
lar basis in cases of moderate to severe AR; an
increased resting HR or an irregularly irregular
rhythm suggesting AF or PVCs indicates pro-
gression.
 The detection of exercise-induced VA is consid-
ered an important negative prognostic indicator.
 Horses with AR and PVCs during exercise are
considered less safe to ride or drive than their
age-matched peers.
 Manage complications of advanced disease. Lim-
ited data have been published about ACE inhibi-
tors and no consensus could be reached regarding
their use in AR in the absence of CHF.
Tricuspid Regurgitation
TR is a common ﬁnding in equine athletes.7,17 The
prevalence and severity of TR appear to be inﬂuenced
by both age and level of training.7,18,19 The precise
mechanisms of training-associated TR are unknown.
Horses with severe MR and PHT associated with
CHF as well as (less commonly) horses with severe
respiratory disease can develop TR. Abnormalities
such as leaﬂet thickening or RCT are infrequently
detected on 2D echocardiography. Endocarditis infre-
quently aﬀects the TV and is typically secondary to
septic jugular thrombophlebitis.20
Diagnosis and Evaluation. A Doppler echocardio-
gram conﬁrms TR but is mainly indicated with a grade
4/6 or louder murmur in the setting of poor perfor-
mance, concurrent thrombophlebitis, or with fever of
unknown origin. An echocardiogram also could be
requested in the setting of a prepurchase examination.
With benign or training-related TR, the valve is
structurally normal, the right atrium (RA) and RV are
normal in size, and the regurgitant jet is usually thin
and directed toward the aorta. With clinically signiﬁ-
cant TR, there might be structural or motion abnor-
malities of the TV with RA and RV enlargement. The
jet width is wider at the origin, tends to occupy a lar-
ger area in the RA, and is often directed centrally or
toward the lateral RA wall. When the TR jet velocity
is >3.5 m/s, PHT is suspected, in which case the horse
should be scrutinized for left-sided heart disease or
severe pulmonary disease.21 TR with RA enlargement
can predispose to atrial ﬂutter, AF or CHF, although
less often than for MR.
Prognosis. Negative prognostic indicators include
TR associated with (1) structural valve lesions (endo-
carditis, RCT, ﬂail leaﬂet); (2) clinical signs of right-
sided CHF; or (3) severe MR and PHT.
Summary: Key Recommendations for TR
 Appreciate the high prevalence of training-
induced TR in high-performance horses.
 Perform comprehensive clinical and echocardio-
graphic examinations when indicated (see above).
 An annual echocardiogram is indicated for
horses with moderate and severe TR.
Ventricular Septal Defect
VSD is the most common congenital heart defect
with some breed predispositions suspected (Section A
Welsh Mountain ponies,22 Standardbreds,23 and Ara-
bian horses23,24). The location of the defect inﬂuences
both auscultation and imaging. The typical VSD is
perimembranous located ventral to the tricuspid leaf-
let, and below the junction of the right and noncoro-
754 Reef et al
nary cusps of the aortic valve.23 Less common lesions
are subarterial (also called subpulmonic or outlet)—
beneath each semilunar valve—and muscular (apical)
VSDs. When the aorta straddles part of ventricular
septum, the descriptor “malalignment” is used and
the risk of aortic valve prolapse increases. VSDs are
often a component of more complex congenital
cardiac defects, whereupon, the associated cardiac
murmurs could diﬀer from those described in
Table 1.
Diagnosis and Evaluation. Deﬁnitive diagnosis requires
an echocardiogram. Complex congenital disease must be
excluded.23,25,26 The size of the VSD is often underesti-
mated with 2D echocardiography and overestimated
with color-ﬂow Doppler echocardiography. The largest
systolic diameter of the defect in two mutually perpendic-
ular planes should be measured. In general, defects
≤2.5 cm in a 450–500 kg horse are less likely to be
hemodynamically important.23
There is usually some enlargement of the left side
of the heart with a left-to-right shunt; however, car-
diac dimensions usually fall within the normal range
if the shunt is small. Moderate to severe enlargement
of the LA and LV is concerning and increases the
risk for AF, PHT, and CHF. Noticeable systolic
enlargement of the pulmonary artery is an indication
of pulmonary overcirculation. Marked pulmonary
artery enlargement during both systole and diastole
suggests PHT.
Provided that there is parallel alignment between
ultrasound beam and shunt ﬂow, the maximal shunt
velocity measured by CW Doppler estimates the pres-
sure gradient across the defect. Peak velocities >4.5 m/s
suggest a restrictive defect with a better prognosis.23
With good alignment peak velocities >5 m/s are
expected. The functional size of the defect can be
reduced by prolapse of the aortic valve into the VSD,
tricuspid valve adhesions, or ﬁbrous tissue prolifera-
tion. Lower shunt velocities (<4 m/s), along with higher
pulmonary artery ejection and mitral inﬂow velocities,
indicate a greater shunt volume.
It is important to identify aortic malalignment, aor-
tic valve prolapse into the VSD with AR, and to detect
MR, TR, or other comorbidities. If moderate to severe
right ventricular wall hypertrophy is found, a large
shunt, PHT, or complex congenital disease should be
assumed.
Prognosis. The most important prognostic criteria
for an isolated VSD include (1) size of VSD; (2) size
of the cardiac chambers; (3) maximal shunt velocity;
(4) presence of signiﬁcant AR or MR; (5) PHT; (6)
CHF. The horse with a small VSD has an excellent
prognosis and should experience a normal performance
life. Moderate defects are often well-tolerated at rest;
although performance in high-intensity sports might be
aﬀected. Progressive MR or AR and cardiac remodel-
ing can facilitate the development of AF, PHT, or
LVD with progressively negative impact on exercise
capacity and eventually on survival. The ﬁnding of a
large diameter, unrestrictive VSD portends a poor
prognosis and shortened life expectancy.
Summary: Key Recommendations for VSD
 Perform comprehensive clinical and echocardio-
graphic examinations.
 Reexamine annually.
 Perform exercise (ECG) testing of horses with
moderate to large VSDs, in prepurchase situa-
tions, or when performance is suboptimal.
 Consider horses with a small VSD and minimal
cardiomegaly as safe to compete; evaluate larger
defects on a case-by-case basis in consultation
with a specialist experienced in equine cardiology.
 Consider aﬀected horses unsuitable for breeding.
Aorto-Cardiac and Aorto-Pulmonary Fistula
A continuous machinery murmur loudest on the
right side of the thorax with bounding arterial pulses
is characteristic of a horse with an aorto-cardiac ﬁs-
tula.27,28 Many horses present with an acute onset of
exercise intolerance and pain, often perceived as colic,
and ventricular tachycardia (VT).27,28
Friesian horses with aorto-pulmonary ﬁstulation
present with bounding arterial pulses, tachycardia, and
a grade 1–3/6 holosystolic and early-to-mid diastolic
murmur loudest dorsal to the aortic valve.29 Although
rare, it often results in acute heart failure or even
SCD, but might also present with a chronic history of
poor performance.
Summary: Key Recommendations for Aorto-cardiac
and Aorto-pulmonary Fistula
 Consider aorto-cardiac ﬁstula in horses with
acute colic and VT, or when a continuous right-
sided murmur is detected.
 Aﬀected horses are not safe to use.
 These horses can experience SCD at any time.
Cardiac Arrhythmias
Arrhythmias can develop as isolated electrical disor-
ders (eg, lone AF or complete heart block) or second-
ary to other etiologic factors, including (1) structural
heart disease; (2) metabolic and endocrine disorders;
(3) systemic inﬂammation; (4) hypotension, hemor-
rhage, anemia, and ischemia; (5) autonomic inﬂuences;
(6) toxicosis/envenomations; and (7) drugs.
General Comments
Electrocardiography (ECG) is the test of choice for
conﬁrming the diagnosis of heart rhythm disturbances.
A base-apex (rhythm strip) ECG is usually suﬃcient,
but additional surface leads, intracardiac leads,30 or
transesophageal leads31 are needed to better evaluate
the ECG waveforms in some cases. A portable ECG
unit is useful in the ﬁeld for documenting arrhythmias.
A continuous 24-hour Holter ECG is indicated to
characterize intermittent arrhythmias. An exercising
ECG is often indicated to determine if an arrhythmia
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has potential for impairing performance or might
become a safety issue.
The workup of the horse with a nonphysiologic
arrhythmia should also include (1) a history including
all drugs and supplements administered; (2) a complete
echocardiogram; and (3) appropriate laboratory tests.
The examiner must be familiar with physiologic,
vagally mediated arrhythmias that include sinus
arrhythmia, second degree AVB, and sinoatrial bock.
These are normal at rest and immediately after exer-
cise.
Second Degree Atrioventricular Block (AVB)
This rhythm is normal in equine athletes. The HR is
in the low normal range and there are usually several
conducted P waves before the AVB. Auscultation is
characterized by an irregular rhythm with a repetitive
pattern. Fourth (atrial) heart sounds that are not fol-
lowed by ﬁrst and second heart sounds might be audi-
ble in the regular pauses in some horses. Physical
activity or increased sympathetic tone should cause the
arrhythmia to disappear, although AVB is likely to
resume quickly.
Diagnosis and Evaluation. In some cases, an exercis-
ing ECG is needed to conﬁrm the physiologic basis of
the arrhythmia. When second degree AV block results
in more than 2 consecutively blocked P waves, the
term “high-grade” is used and the rhythm considered
abnormal. If the horse with high-grade second degree
AVB cannot be exercised, an atropine response test
can be used to determine if a 1 : 1 conduction devel-
ops. A continuous 24-hour Holter ECG with simulta-
neous video recording should be obtained when there
is a history of collapse.
Summary: Key Recommendations for High-Grade
Second Degree AVB
 Horses with high-grade second degree AVB that
disappears with exercise should only be ridden or
driven by an informed adult, and the HR and
rhythm should be frequently monitored.
 Horses with high-grade second degree AVB dur-
ing exercise or after atropine administration
should be rested and re-evaluated; they are con-
sidered less safe to ride or drive than their age-
matched peers.
 Horses with symptomatic bradyarrhythmias gen-
erally have a poor prognosis and are not safe to
ride or drive.
Atrial Fibrillation
Atrial ﬁbrillation (AF) is the most common arrhyth-
mia aﬀecting performance. In some Standardbred race-
horses, it has been identiﬁed as a heritable lesion.32
With acute onset of AF, spontaneous conversion to
normal sinus rhythm (NSR) can occur, usually within
24–48 hours. This is referred to as paroxysmal AF.
AF in the absence of detectable underlying heart
disease is called lone AF. Microstructural lesions or
channelopathies that predispose to AF might be
present in some of these horses, but cannot be detected
using routine diagnostic tests. Structural heart diseases
can predispose horses to recurrent or persistent AF.
AF is usually recognized during auscultation and is
characterized by an irregularly irregular rhythm that
can sound like a combination of premature beats and
long pauses. The atrial (fourth) sound is absent. The
resting HR is usually normal. Resting tachycardia sug-
gests underlying heart disease, sympathetic nervous
system (SNS) stimulation because of stress or pain, or
in unusual cases, presence of an accessory atrioventric-
ular conduction pathway. Some horses have AF with a
patterned AV conduction sequence that must be distin-
guished from second degree AVB. Although AF often
sounds more regular at higher HRs, the rhythm
remains irregular and careful auscultation will reveal
this. Horses with AF also should be examined criti-
cally for relevant murmurs that might indicate the pre-
sence of atrial enlargement and remodeling, creating a
substrate for AF.
Diagnosis and Evaluation. The diagnosis is con-
ﬁrmed with an ECG, which is characterized by an
irregularly irregular R-R interval with normal QRS
morphology, the absence of P waves and the presence
of “f” waves. Concurrent PVCs might be found. Atrial
ﬂutter represents a slow macro-reentry variation on
AF. Flutter waves resemble saw-toothed P waves with-
out an isoelectric shelf and have a regular atrial rate of
about 170–275/min, while ﬁbrillation waves are less
organized and faster (275–500/min on intracardiac
electrograms). AV conduction in atrial ﬂutter is usually
variable, resulting in a ventricular rate response that
can be irregular or regular during periods of increased
sympathetic tone. Patterns of 3 : 1, 2 : 1, or 1 : 1
atrial-to-ventricular conduction can be observed.
A complete echocardiogram should be performed to
identify any underlying structural heart disease, valvu-
lar regurgitation, and cardiac (atrial) enlargement as
described above. A slight increase in LA size can result
from AF, even in the absence of MR. Additionally, an
ECG exercise test should always be performed when a
horse is used for performance and cardioversion is not
an option or could not be attained.33
The suspected duration of AF should be determined
when possible because it aﬀects the prognosis for suc-
cessful conversion and the likelihood of recurrence.34
AF induces time-dependent electrical and structural
remodeling within the atria, factors known to promote
its persistence.30,35–37 These changes might also
decrease the chance of successful cardioversion and
increase the risk of recurrent or persistent AF, even
after successful treatment.30 Additionally, atrial disease
might be associated with recurrent premature atrial
complexes (PACs) that can act as triggers for recurrent
AF after successful treatment. A sudden change in per-
formance and results of previous veterinary examina-
tions provide the best estimate for the onset of the
AF. When this information is lacking, it should be
assumed that AF is long-standing. Signiﬁcant LA
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enlargement reduces the likelihood of successful
cardioversion and increases the risk for recurrence.
Horses with AF secondary to CHF or with PHT have
a grave prognosis and should be retired.
Evidence of LVD, typically a decreased shortening
fraction, might indicate underlying myocardial disease
in the horse with AF.38 However, assessment of LV
function is hampered during AF because of ventricular
dyssynchrony, tachycardia-induced LV dysfunction
and preload and HR dependence of many of the echo-
cardiographic indices used to assess LV function. If
horses fail to return to their previous level of perfor-
mance after AF has been successfully corrected, then
persistent LVD should be suspected.
The level of intended activity inﬂuences clinical deci-
sion making as sustained AF is likely to limit rigorous
athletic work and occasionally impairs performance at
mid to low levels of activity. Other horses with persis-
tent AF are able to perform successfully when used for
less intense athletic work. However, cardioversion of
AF is recommended when the average maximal HR
during exercise at an intensity that is at or slightly
exceeding the horse’s normal activities is greater than
220/min. Although uncommon, collapse during exer-
cise has been reported with AF. Additionally, ventricu-
lar ectopy during exercise or during SNS stimulation
indicates a possible risk for SCD, particularly when
short R-R intervals or R-on-T phenomenon are
observed. AF associated with exercise-induced VA
resulting in SCD has been documented in at least one
horse.4 For this reason, treatment for AF is also rec-
ommended when concurrent VA are observed.33 These
usually resolve after cardioversion.
Management strategies for AF include no treatment,
pharmacologic cardioversion, and transvenous electri-
cal cardioversion (TVEC). Details have been described
elsewhere.38–49 Horses with CHF and AF should be
treated for CHF and are not candidates for cardiover-
sion.
Cardioversion is generally not performed for the
ﬁrst 24–48 hours of a documented, recent onset of AF
because spontaneous cardioversion might occur. How-
ever, after spontaneous cardioversion, an evaluation is
still indicated, including measurement of serum K+,
and Mg++, fractional excretion of K+ (in racehorses),
echocardiography, continuous 24-hour ECG, and opti-
mally an exercising ECG test to identify atrial triggers
or other arrhythmias. These tests are also appropriate
in a horse with NSR if paroxysmal AF is suspected
from the clinical history. However, if AF persists
beyond 48 hours, prompt treatment of AF is recom-
mended to deter progressive atrial remodeling.
Cardioversion to NSR. Cardioversion is desirable in
all horses performing rigorous athletic work. Success-
ful treatment allows a return to the previous level of
performance, assuming an absence of clinically rele-
vant underlying cardiac disease. Cardioversion of AF
should only be performed in a controlled setting with
continuous (ECG) monitoring, regardless of the treat-
ment method. There are no prospective, randomized
studies directly comparing the eﬃcacy of quinidine to
TVEC. Success rates of 65–90% have been reported
for both. Young racehorses with lone AF probably
have a better prognosis for successful cardioversion,
independent of treatment modality. Horses with
advanced valvular heart disease and moderate to
severe atrial enlargement are poorer candidates for
cardioversion and long-term maintenance of NSR.
Quinidine sulfate is the mainstay of pharmacologic
cardioversion of AF.34 Indications for quinidine treat-
ment include lone AF, AF with mild LA enlargement,
and comorbidities in which general anesthesia or
TVEC are not options. Relative or absolute contrain-
dications to quinidine cardioversion include rapid ven-
tricular response to AF and complex ventricular
ectopy owing to the proarrhythmic eﬀect of quinidine
and risk of polymorphic VT. Quinidine also carries the
risk for adverse drug eﬀects that necessitates close
monitoring, and sometimes discontinuation of treat-
ment or coadministration of other drugs (such as
digoxin) to control the ventricular response rate. The
reader is directed elsewhere for details.34,38,43,44
TVEC involves a timed shock delivery on the
R-wave. The procedure should be performed by expe-
rienced operators using specialized equipment. TVEC
can be used to treat lone AF, AF with mild LA
enlargement, and horses either intolerant of or unre-
sponsive to quinidine treatment or horses in which
quinidine is contraindicated (see above).39 The risks of
TVEC include general anesthesia50,51 or rarely, devel-
opment of a fatal arrhythmia.52 The immediate recur-
rence of AF (IRAF) within the ﬁrst 24 hours after
cardioversion, although infrequent, is more likely than
with quinidine cardioversion. Pretreatment with antiar-
rhythmic drugs before TVEC or administration of an
antiarrhythmic drug during and after anesthesia might
minimize the likelihood of IRAF.45,53 In the long term,
recurrence rates after TVEC and quinidine cardiover-
sion are believed to be similar. The reader is referred
elsewhere for a more detailed description of the proce-
dure.39–42,45,54
PostCardioversion. Recurrent atrial arrhythmias can
be observed in some horses following successful car-
dioversion and these are best identiﬁed using a contin-
uous 24-hour ECG. However, the optimal timing of
this examination, the inﬂuence of premature atrial
complexes on long-term prognosis, and the best
approach to management of recurrent atrial ectopy are
unknown. A complete echocardiogram after cardiover-
sion can evaluate LV and LA mechanical function and
reassess heart size and valvular function. LV function
should return to normal within 3 days.38 Recovery of
LA contractile function can occur within a few days or
might take several weeks when AF has been long-last-
ing.53,55,56 Persistent LA contractile dysfunction can be
caused by AF-induced atrial remodeling or underlying
primary cardiomyopathy and might portend recurrent
AF.
Most recommendations to minimize the risk of AF
recurrence are based on human studies or experimental
animal models. Chronic antiarrhythmic drug treatment
potentially eﬀective against atrial arrhythmias in
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human patients includes propafenone, sotalol, ﬂecai-
nide, amiodarone, and phenytoin. While these could
be beneﬁcial to horses with frequent atrial ectopy after
cardioversion, clinical studies of eﬃcacy and safety are
needed. Drugs known to predispose to ectopic impulse
formation should be avoided, including furosemide,
supplements containing sodium bicarbonate, and thy-
roid hormones. Potassium chloride supplementation is
indicated in most horses administered furosemide
before racing or in those with low fractional urinary
excretion of potassium.
The type of AF, AF duration, and concurrent car-
diac abnormalities help determine the time out of
training following cardioversion. Ideally, rest is
enforced until atrial electrical and contractile function
has normalized or nearly so. Horses with paroxysmal
AF and short-duration, lone AF can return to training
within 1 week unless LA stunning or postconversion
arrhythmias are detected. Horses with long-standing
AF might need a month or longer of rest.53
Recurrence of AF. The recurrence rate of AF is low-
est (about 15%) with lone AF of recent onset
(≤1 month).34,39 Recurrence rate of AF is higher in
horses with underlying cardiac disease, especially
chronic valvular regurgitation with atrial enlargement.
Horses with a high number of PACs or runs of atrial
tachycardia are more likely to experience recurrent AF,
and these ECG ﬁndings should be considered a poor
prognostic indicator. Persistent LA mechanical dysfunc-
tion is thought to indicate irreversible atrial remodeling
and might also represent a poor prognostic sign.
Summary: Key Recommendations for AF
 Select the most appropriate method of cardiover-
sion based on the risk factors for pharmacologic
cardioversion or TVEC.
 Perform a continuous 24-hour ECG and ideally
evaluate LA function after cardioversion.
 Return to training within 1 week with paroxys-
mal AF or short-duration lone AF if normal
after cardioversion; rest horses with long-stand-
ing AF for 4–6 weeks.
 Avoid the use of furosemide, supplements con-
taining sodium bicarbonate, and thyroid hor-
mones after cardioversion.
 Supplement oral potassium chloride to horses
administered furosemide before racing or demon-
strating low fractional excretion of potassium.
 Because safety is a concern with persistent AF,
the horse should be cardioverted or retired when
the exercising HR during sustained maximal
exercise exceeds 220 beats/min or if concurrent
VA are detected during exercise or with SNS
stimulation.
 Horses with persistent AF should only be ridden
or driven by an informed adult and limited to an
exercise level considered relatively safe based on
an exercising ECG. The use of a HR monitor
might be useful to track heart rate during exer-
cise and modify the rigor of the work performed.
Premature Atrial Complexes
PACs are usually detected during auscultation as
premature beats interrupting an otherwise regular
rhythm. At times, PACs are diﬃcult to diﬀerentiate
from marked sinus arrhythmia. PACs are an uncom-
mon cause for poor performance. The greatest concern
about PACs relates to their potential to incite atrial
ﬂutter and AF.
The ECG is needed for deﬁnitive diagnosis, and con-
tinuous ECG monitoring enables the clinician to more
completely characterize the atrial ectopy. PACs are
characterized by ectopic, premature atrial activation
(P0), usually with changes in normal P-wave morphol-
ogy. PACs can be conducted with a variable P0-R inter-
val or blocked at the AV node. PACs are easily missed
when buried in the ST segment or T wave, especially at
higher HR. The conducted QRS is generally normal in
morphology, but ventricular conduction can be aber-
rant resulting in wider, taller or bizarre QRS complexes
with secondary ST segment and T wave changes.
Summary: Key Recommendations for PACs
 A continuous 24-hour ECG is recommended to
assess frequent PACs.
 Horses with occasional PACs that are overdriven
during exercise and those with occasional PACs
during exercise are considered as safe to ride or
drive as their age-matched peers.
 Underlying causes should be sought.
 The risk for AF should be appreciated.
Premature Ventricular Complexes and Ventricular
Tachycardia
PVCs are also usually detected during auscultation
and are characterized by premature beats interrupting
an otherwise regular rhythm, usually followed by a
compensatory pause. VT is an abnormal rhythm
caused by 3 or more repetitive or linked PVCs. Aus-
cultation of VT is characterized by a rapid, usually
regular rhythm, with variable intensity and often
booming heart sounds (“bruit de cannon”). Because of
intermittent aortic valve opening, the rhythm can
sound irregular on auscultation and an intermittent
pulse deﬁcit could be present. Abnormal jugular pulses
(cannon waves) are frequently observed.
An ECG is needed for deﬁnitive diagnosis. PVCs
are characterized by premature ventricular activation
without an associated P wave. The QRS complex is
typically wide and bizarre and followed by a large T
wave of opposite polarity. Impulses arising from high
in the ventricle (near the bundle of His) can be diﬃcult
to distinguish from a junctional (nodal) rhythm.
Deﬁning the safety risks to the horse and to the
rider or driver is paramount in cases of ventricular
ectopy. The complexity of a ventricular arrhythmia
(see below) is presumed to relate to the risk of hypo-
tension and sudden cardiac death (SCD) because of
ventricular ﬁbrillation (VF). However, risk stratiﬁca-
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tion for VA is imperfect. In the absence of clear evi-
dence, the panel believes recommendations should be
biased toward safety, as opposed to maintaining ath-
letic activity. A history of collapse raises great concern
in a horse with PVCs. Similarly ventricular ectopy in
association with important structural heart disease (and
cardiomegaly) poses another long-term safety concern
(as discussed above, exercise ECGs are generally rec-
ommended for those horses). Detection of systemic
hypotension during a documented run of VT is another
indication of a serious arrhythmia. But in the absence
of clinical signs or of serious structural heart disease,
the risk of ventricular ectopy is usually deﬁned by elec-
trocardiographic characteristics, accepting the limita-
tions of this analysis. This assessment includes the
morphology, timing, and rate of the ectopic activity.
PVCs can be characterized by QRS complex mor-
phology, including uniform or multiform appearance;
number (singles, couplets, or VT); average frequency
(per hour or per 24 hours); distributional pattern (eg,
haphazard, bigeminy, interpolated); coupling interval
relative to the previous QRS complex (ﬁxed versus
variable; short coupling versus late-diastolic); and pre-
maturity or timing relative to the previous QRS-T (as
with ‘R-on-T’ complexes). Runs of VT are further
classiﬁed by their rate (absolute rate/min and rate rela-
tive to the sinus node); duration of VT (nonsustained
versus sustained), and morphology (uniform versus
polymorphic, including torsades de pointes). As a gen-
eral rule, the following are features of complex or
potentially “malignant” VA: multiform or polymor-
phic QRS morphology; short coupling intervals (espe-
cially R-on-T timing); sustained VT; rapid ventricular
rate (exceeding 120 beats/min); and repetitive ectopic
activity (couplets, VT). Polymorphic VT can be
observed with diﬀuse myocardial disease or with drug
toxicity (quinidine toxicosis) and induces both hemo-
dynamic and electrical instability. Conversely, the well-
tolerated accelerated idioventricular rhythm (AIVR)
tends to be monomorphic, start with a relatively long
coupling interval, and become established at relatively
slow ventricular rates (50–80/min at rest).
Occasional monomorphic PVCs overdriven with
exercise or only detected in the immediate postexercise
period are not usually a cause for poor performance.
A wide range of VA occur during and immediately
after intense exercise in normally performing horses.57–
60 The importance of these arrhythmias and the risk of
SCD requires further investigation. PVCs can also
occur during exercise and are a cause for concern.
Their relationship with poor performance is also
uncertain and requires further investigation.
Assessment of the overall clinical picture is impor-
tant because VA can be associated with medical or
surgical disorders and often resolve with correction of
the underlying problem. A clinical laboratory proﬁle,
including plasma or serum cardiac troponin I (cTnI)
concentration should be obtained from aﬀected horses.
While an echocardiogram might be valuable in any
horse with VA, this test is speciﬁcally recommended
for horses with VT or complex VA; when VA is recur-
rent or persistent; or when VA is identiﬁed in the clini-
cal settings of poor performance, collapse, a clinically
relevant cardiac murmur, or a moderately to severely
increased cTnI. The echocardiogram should include
imaging for abnormal myocardial echo texture, thick-
ness, or scar, and exclusion of dissecting aortic aneu-
rysm or aorto-cardiac ﬁstula. LVD might be secondary
to tachycardia-induced cardiomyopathy or ventricular
dyssynchrony. In horses with sustained VT, the echo-
cardiogram should be repeated once the horse has
returned to NSR. A continuous 24-hour ECG should
also be obtained to more completely evaluate the VA
as they are often intermittent. Further workup of a
horse with PVCs or AIVR, in the absence of underly-
ing systemic disease, should include an exercising
ECG. Horses with VT or complex VA should not be
exercise tested.
Summary: Key Recommendations for PVCs and VT
 Underlying causes should be sought and man-
aged if possible.
 Horses with occasional PVCs at rest or during
exercise or with sustained AIVR that is over-
driven by exercise can be ridden or driven with
caution by an informed adult. Owing to ongo-
ing concerns about underlying myocardial or
electrical disease and increased risks of exercise
associated collapse and SCD, these horses
should not be used by a child or as a lesson
horse.
 Horses with sustained monomorphic VT should
be rested and treated. NSR should be present
for at least 4 weeks before re-evaluation is per-
formed. A continuous 24-hour ECG is indicated
before returning the horse to work. If normal,
an exercising ECG should be performed, fol-
lowed by another exercising ECG once the
horse has returned to full work. Horses aﬀected
by a single episode generally have a favorable
prognosis, but on occasion monomorphic VT
can recur.
 Horses with symptomatic or complex VA should
be rested and treated. Follow-up examinations
are similar as for horses with sustained mono-
morphic VT although the safety of these horses
remains uncertain. These horses should only be
ridden or driven by an informed adult.
 Rigorous athletic work is not recommended for
horses that showed VA in the setting of moder-
ate or severe structural heart disease, including
echocardiographic lesions suspected to indicate
myocardial ﬁbrosis or scar, and moderate to
severe AR. These horses should only be ridden
or driven by an informed adult because of the
risk of possible recurrence of VT. These horses
are not safe for use by a child or as a lesson
horse.
 For horses with a history of VT that remain in
work follow-up 24-hour and exercising ECGs
should be performed at least annually.
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Areas for Future Research Investigation
Large multicenter clinical studies are indicated to
develop a comprehensive assessment of the severity of
valvular regurgitation, its progression, outcome, and
the eﬀect of ACE inhibitors in horses with moderate
to severe MR and AR. The methods for echocardio-
graphic assessment of cardiac structures, size, and
function should be standardized. Critical assessments
of the eﬃcacy of diﬀerent treatments for AF and the
factors aﬀecting its recurrence are indicated. The
reproducibility of continuous 24-hour Holter ECG
monitoring and exercising ECGs also needs to be
determined. Large studies in diﬀerent populations of
performance horses are needed to further study the ar-
rhythmias present during exercise and their relation-
ship with horse and rider or driver safety and SCD.
Summary: Key Recommendations for Research
Investigation
 Standardization of echocardiographic methods.
 Comparative eﬃcacy of quinidine and TVEC.
 Pharmacotherapy to prevent recrudescence of AF.
 Risk of VA and SCD with AR.
 Reﬁning exercise testing for speciﬁc sports.
Collaboration between diﬀerent investigators on these
and other studies will help further advance the knowl-
edge of cardiac disease in the equine athlete and the
development of appropriate recommendations.
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